✦ LIBER ✦

1109 HIGH VS STANDARD DOSE OF RIBAVIRIN PLUS PEGINTERFERON-ALFA-2A IN CHRONIC HEPATITIS C, GENOTYPE 3 AND HIGH VIRAL LOAD. FINAL RESULTS OF THE DARGEN-3 STUDY

✍ Scribed by Rodriguez, C.M. Fernandez; Masnou, H.; Morillas, R.; Navarro, J.M.; Barcena, R.; Hernandez, J.M.; Martin Martin, L.; Garcia Poyato, A.; Miquel Planas, M.; Jorquera, F.; Casanova, T.; Romero-Gómez, M.; Salmeron, J.; Calleja, J.L.; Solà, R.

Book ID: 123587618
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 61 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(12)61121-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized clinical trial comparing high

Randomized clinical trial comparing high versus standard dose of ribavirin plus peginterferon alfa-2a in hepatitis C genotype 3 and high viral load. Dargen-3 study

✍ Fernández-Rodríguez, Conrado M.; Morillas, Rosa María; Masnou, Helena; Navarro, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 Spanish ⚖ 852 KB

Sa1055 Final Results of a Clinical Trial

Sa1055 Final Results of a Clinical Trial of a 2-Week Lead-in Therapy With Interferon Beta Plus Ribavirin Before Peginterferon alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 1 and High Viral Loads

✍ Sato, Ken; Ohyama, Tatsuya; Hashizume, Hiroaki; Horiguchi, Norio; Yamazaki, Yuic 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

The effectiveness of retreatment with pe

The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil

✍ Simara Artico, Karine Medeiros Amaral, Candice Beatriz Treter Gonçalves, Paulo D 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 196 KB

S1942 A Randomized Trial of Standard vs.

S1942 A Randomized Trial of Standard vs. Dose-Escalation Dosing of Ribavirin in Combination Therapy for Chronic Hepatitis C Patients with Genotype 1 and High Viral Load

✍ Iwasaki, Yoshiaki; Araki, Yasuyuki; Okamoto, Ryo-ichi; Taniguchi, Hideaki; Makin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 121 KB

57 ACTIVITY OF TELAPREVIR ALONE OR IN CO

57 ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: FINAL RESULTS OF STUDY C209

✍ G.R. Foster; C. Hezode; J.-P. Bronowicki; G. Carosi; O. Weiland; L. Verlinden; R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 93 KB

1044 TELAPREVIR IN HEPATITIS C GENOTYPE-

1044 TELAPREVIR IN HEPATITIS C GENOTYPE-1-INFECTED PATIENTS WITH PRIOR NON-RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE TO PEGINTERFERON- ALFA-2A/B AND RIBAVIRIN THERAPY: SVR RESULTS OF THE PROVE3 STUDY

✍ Manns, M.; Muir, A.; Adda, N.; Jacobson, I.; Afdhal, N.; Heathcote, J.; Zeuzem, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 91 KB